This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (311) Neurology and Neurosciences (185) Safety and Error Prevention in Health (202) Wearable Devices and Sensors (888) Neurotech Innovations, Diagnostic Tools and Techniques (33)

Published on in Vol 10, No 10 (2021): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29695, first published .
A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

Authors of this article:

Fatima Jamali1 Author Orcid Image ;   Mayis Aldughmi2 Author Orcid Image ;   Mohammad W Khasawneh1 Author Orcid Image ;   Said Dahbour3, 4 Author Orcid Image ;   Alaa A Salameh1 Author Orcid Image ;   Abdalla Awidi1, 5 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Soares M, Gonçalves R, Vasques J, da Silva-Junior A, Gubert F, Santos G, de Santana T, Almeida Sampaio G, Silva D, Dominici M, Mendez-Otero R. Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases. Frontiers in Molecular Neuroscience 2022;15 View